STAGE IIIA INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Clinical trials for STAGE IIIA INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat bile duct cancer
Disease control OngoingThis early-phase study tests a new treatment for advanced bile duct cancer that has spread. It combines a special type of radiation (given in higher doses over fewer sessions) with an immunotherapy drug called bintrafusp alfa, which helps the immune system fight cancer. The goal …
Matched conditions: STAGE IIIA INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:15 UTC
-
New combo shows promise against tough liver cancer
Disease control OngoingThis study tests a new drug called pevonedistat, given alone or with standard chemotherapy, in 40 adults with advanced bile duct cancer that has spread or cannot be removed. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must have …
Matched conditions: STAGE IIIA INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:59 UTC